Proxy filing
Logotype for NextCure Inc

NextCure (NXTC) Proxy filing summary

Event summary combining transcript, slides, and related documents.

Logotype for NextCure Inc

Proxy filing summary

24 Apr, 2026

Voting matters and shareholder proposals

  • Election of two Class I Directors: Anne Borgman, M.D. and John G. Houston, Ph.D. are nominated for election.

  • Ratification of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026.

  • Advisory approval of executive compensation for named executive officers.

  • Approval of an amendment and restatement of the 2019 Omnibus Incentive Plan, including an increase in authorized shares for issuance.

  • Proxies are authorized to vote on other business that may properly come before the meeting.

Board of directors and corporate governance

  • Two nominees are presented for election to the board as Class I Directors.

Executive compensation and say-on-pay

  • Advisory vote is sought for the compensation paid to named executive officers.

  • Amendment to the 2019 Omnibus Incentive Plan includes increasing the number of shares available for executive and employee incentives.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more